Substantial contract win for Proteome Sciences

December 20, 2021

Proteome Sciences is pleased to announce that the Company has secured a contract in excess of GBP 1 million from a major pharmaceutical company to analyse large cohorts of clinical samples from a phase 3 clinical trial. Work is expected to start early in the first quarter of 2022 and the majority of revenue is expected to be generated in 2022.

View PDF Version

« Back To News